Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nucleic Acids02:43

Nucleic Acids

49.8K
Nucleic acids are the most important macromolecules for the continuity of life. They carry the cell's genetic blueprint and carry instructions for its functioning.
DNA and RNA
The two main types of nucleic acids are deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). DNA is the genetic material in all living organisms, ranging from single-celled bacteria to multicellular mammals. It is in the nucleus of eukaryotes and in the organelles, chloroplasts, and mitochondria. In prokaryotes,...
49.8K
Nucleic acids02:43

Nucleic acids

188.5K
Nucleic acids are the most important macromolecules for the continuity of life. They carry the cell's genetic blueprint and carry instructions for its functioning.
DNA and RNA
The two main types of nucleic acids are deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). DNA is the genetic material in all living organisms, ranging from single-celled bacteria to multicellular mammals. It is in the nucleus of eukaryotes and in the organelles, chloroplasts, and mitochondria. In prokaryotes,...
188.5K
Kinetic Screening of Nuclease Activity using Nucleic Acid Probes06:52

Kinetic Screening of Nuclease Activity using Nucleic Acid Probes

8.7K
Altered nuclease activity has been associated with different human conditions, underlying its potential as a biomarker. The modular and easy to implement screening methodology presented in this paper allows the selection of specific nucleic acid probes for harnessing nuclease activity as a biomarker of...
8.7K
A Polyaniline-based Sensor of Nucleic Acids07:58

A Polyaniline-based Sensor of Nucleic Acids

8.4K
Nucleic acids are common analytes for assessing biological systems; however, bias from enzymatic manipulation can cause concern. Here a method is described for label-free detection of nucleic acids using polyaniline. This sensitive, cost-effective sensor technology can distinguish single nucleotide differences between...
8.4K
Streptozocin Treatment: A Zebrafish Model of Type 1 Diabetes Mellitus04:26

Streptozocin Treatment: A Zebrafish Model of Type 1 Diabetes Mellitus

3.1K
This video describes the technique of creating a zebrafish model for Type 1 diabetes mellitus with the help of the drug Streptozocin, to study the pathophysiology of diabetic complications and metabolic...
3.1K
A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes05:18

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

5.6K
The streptozotocin-induced diabetic wound model in male SD rats is currently the most widely used model for studying wound healing in type I diabetes mellitus. This protocol describes the methods used to construct this model. It also presents and addresses potential challenges and examines the progression and angiogenic characteristics of diabetic wounds.
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of PSMA-Targeted Liposomal Zinc for Prostate Cancer Therapy.

Nanomaterials (Basel, Switzerland)·2026
Same author

Machine learning and natural language processing for the identification of potential mental disorders among school-age children: a prospective birth cohort study.

BMC medicine·2026
Same author

The Multifaceted Role of microRNA-10b (miR-10b) in Glioblastoma: From Oncogenic Driver to Therapeutic Target.

Cells·2026
Same author

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models.

Journal of visualized experiments : JoVE·2026
Same author

Template-Directed RIG-I Agonist Assembly for Image-guided Targeted Cancer Immunotherapy.

Molecular imaging and biology·2026
Same author

Gendered risks to children and adolescents assessed by Child & Adolescent Mental Health Services (CAMHS): Perspectives from network analysis.

Child abuse & neglect·2026

Related Experiment Video

Updated: Jan 20, 2026

Kinetic Screening of Nuclease Activity using Nucleic Acid Probes
06:52

Kinetic Screening of Nuclease Activity using Nucleic Acid Probes

Published on: November 1, 2019

8.7K

Nucleic acid-based theranostics in type 1 diabetes.

Bennett Francis Dwan1, Anna Moore2, Ping Wang2

  • 1Precision Health Program, Department of Radiology, College of Human Medicine, Michigan State University, East Lansing, Michigan; College of Natural Science, Michigan State University, East Lansing, Michigan.

Translational Research : the Journal of Laboratory and Clinical Medicine
|September 7, 2019
PubMed
Summary
This summary is machine-generated.

RNA interference (RNAi) shows promise for type 1 diabetes (T1D) treatment. This review covers oligonucleotide delivery methods, monitoring techniques, therapeutic targets, and theranostic strategies for T1D.

More Related Videos

Nucleic Acid Chemistry: DNA and RNA
02:43

Nucleic Acid Chemistry: DNA and RNA

49.8K
Nucleotides and Nucleic Acids
02:43

Nucleotides and Nucleic Acids

188.5K

Related Experiment Videos

Last Updated: Jan 20, 2026

Kinetic Screening of Nuclease Activity using Nucleic Acid Probes
06:52

Kinetic Screening of Nuclease Activity using Nucleic Acid Probes

Published on: November 1, 2019

8.7K
Nucleic Acid Chemistry: DNA and RNA
02:43

Nucleic Acid Chemistry: DNA and RNA

49.8K
Nucleotides and Nucleic Acids
02:43

Nucleotides and Nucleic Acids

188.5K

Area of Science:

  • Biomedical Engineering
  • Molecular Medicine
  • Immunology

Background:

  • Type 1 diabetes (T1D) is an autoimmune disease characterized by pancreatic beta cell destruction.
  • Current T1D management focuses on glycemic control and insulin replacement.
  • Novel therapeutic strategies are needed to address the underlying autoimmune pathology and beta cell loss.

Purpose of the Study:

  • To review the potential of RNA interference (RNAi) as a therapeutic modality for T1D.
  • To explore advancements in oligonucleotide delivery systems for targeted therapy.
  • To discuss theranostic approaches integrating diagnosis and therapy for T1D.

Main Methods:

  • Literature review of RNAi applications in T1D.
  • Analysis of oligonucleotide delivery vehicles (e.g., nanoparticles, viral vectors).
  • Examination of imaging techniques for monitoring delivery and therapeutic response.

Main Results:

  • RNAi offers a targeted approach to modulate gene expression implicated in T1D pathogenesis.
  • Various delivery systems are being developed to enhance oligonucleotide stability and cell-specific targeting.
  • Theranostic strategies can enable real-time monitoring of treatment efficacy and disease progression.

Conclusions:

  • RNAi-based therapies represent a promising avenue for T1D treatment, potentially addressing autoimmune mechanisms.
  • Optimized delivery and monitoring are critical for successful clinical translation of RNAi for T1D.
  • Integrated theranostic approaches could revolutionize T1D management by personalizing treatment strategies.